Analyst Ratings for Eagle Pharmaceuticals Inc. (EGRX)Updated: 2017-07-28
An average rating of Overweight has been given to Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) by analysts covering the stock. EGRX had previously received a consensus rating of Overweight a month ago.
A buy rating was issued by 3 analysts, 0 gave an overweight rating, 0 issued a hold rating, 1 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.
Investment analysts gave a few price targets for EGRX. The maximum price target given was 118, which equates to a potential upside of 132.47 percent. The lowest price target was 57, which equates to a potential downside of 12.29 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.
Analysts have revised their earnings estimates upwards for this quarter, by about 0 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is -23.85 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of -6.27 percent in FY estimates.
People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts made negative revisions. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.
EGRX has an estimated earnings growth rate of -46.64 percent as forecasted by analysts. The PEG ratio of a stock is another value frequently studied by investors. Smaller PEG ratios are desirable, as that can indicate whether the high price level of a stock is warranted by high growth. Wall Street investors typically prefer a PEG ratio to be smaller than 1, but many choose to perform ratio comparisons with other companies in the industry. The PEG ratio of EGRX is -0.17.
EGRX has a 52-week high of 97.15 and a 52-week low of 42.33. The current market price is above the trailing year's low by 19.91 percent, and 47.75 percent lower than its 52-week high. EGRX has a price/earnings ratio of 7.87. Investors typically compare the P/E ratio to a company's peers in the industry. The EGRX value stock report compares EGRX to some of its peers using value stock charts. The stock has a market capitalization of $0.80613 billion. EGRX will post this quarters earnings in days, on 0000-00-00.